Peripheral arterial disease in older people with intellectual disability in The Netherlands using the ankle-brachial index: results of the HA-ID study.

Older people with an intellectual disability (ID) have been shown to have similar to increased cardiovascular risks as compared to the general population. Peripheral arterial disease (PAD), atherosclerosis distal from the aortic bifurcation, is associated with increased cardiovascular morbidity and mortality. The prevalence of PAD has not been investigated in this population. Therefore, the aim of the present study was to determine the prevalence of PAD in older people with ID in The Netherlands, the rate of prior diagnoses, and correlations with participant characteristics, and to compare the prevalence with PAD in the general Dutch population. 771 people aged 50 years and over participated in ankle-brachial index (ABI) measurement as part of a multi-centre cross-sectional study (HA-ID study). PAD was defined as an ABI<0.9. After excluding those, who met the exclusion criteria, 629 participants remained. PAD was present in 20.7% of the participants and 97% had not been diagnosed before. People with higher age, smokers and people who lived in central settings, walked with support and were more dependent in activities of daily living were more at risk of PAD. Prevalence of PAD is higher than in the general population (17.4% of 562 eligible participants with ID, as compared to 8.1% of 917 Dutch participants of the PANDORA study, a pan-European study into the prevalence of PAD) through all age groups. Because the high prevalence of PAD implies a serious health risk for older people with ID, we recommend that ankle-brachial index measurement is to be routinely performed as part of the cardiovascular risk management in this group.

Association of the TGF-beta receptor genes with abdominal aortic aneurysm.

Abdominal aortic aneurysm (AAA) is a multifactorial condition. The transforming growth factor beta (TGF-beta) pathway regulates vascular remodeling and mutations in its receptor genes, TGFBR1 and TGFBR2, cause syndromes with thoracic aortic aneurysm (TAA). The TGF-beta pathway may be involved in aneurysm development in general. We performed an association study by analyzing all the common genetic variants in TGFBR1 and TGFBR2 using tag single nucleotide polymorphisms (SNPs) in a Dutch AAA case-control population in a two-stage genotyping approach. In stage 1, analyzing 376 cases and 648 controls, three of the four TGFBR1 SNPs and nine of the 28 TGFBR2 SNPs had a P<0.07. Genotyping of these SNPs in an independent cohort of 360 cases and 376 controls in stage 2 confirmed association (P<0.05) for the same allele of one SNP in TGFBR1 and two SNPs in TGFBR2. Joint analysis of the 736 cases and 1024 controls showed statistically significant associations of these SNPs, which sustained after proper correction for multiple testing (TGFBR1 rs1626340 OR 1.32 95% CI 1.11-1.56 P=0.001 and TGFBR2 rs1036095 OR 1.32 95% CI 1.12-1.54 P=0.001 and rs4522809 OR 1.28 95% CI 1.12-1.46 P=0.0004). We conclude that genetic variations in TGFBR1 and TGFBR2 associate with AAA in the Dutch population. This suggests that AAA may develop partly by similar defects as TAA, which in the future may provide novel therapeutic options.

[Thromboprophylaxis in general surgical practices in the year 2004: perioperative use during hospitalisation, during out-patient care and following plaster cast immobilisation]. / Tromboseprofylaxe in de algemene chirurgische praktijk anno 2004: rond ingrepen tijdens opname, tijdens dagbehandeling en na gipsimmobilisatie.

OBJECTIVE: To determine which thromboprophylactic modalities were used by general surgeons in the Netherlands; to check current clinical practice against national and international guidelines. DESIGN: Descriptive. METHOD: In April 2004 a questionnaire was sent to all 106 surgical practices in the Netherlands with questions regarding the use of thromboprophylaxis before, during and after various surgical interventions. Practice was compared with guidelines from the Dutch Institute for Healthcare Improvement CBO, the Dutch Surgical Association and the American College of Chest Physicians. RESULTS: We obtained data from 92 (87%) surgical practices. Low molecular weight heparin was initiated before surgery by 92% of respondents. Risk factors such as age (72%) and prior venous thromboembolism (76%) played an important role in determining the thromboprophylactic protocol used. During hospitalisation, variations were seen primarily for operations performed on an out-patient basis: 61% of surgeons gave thromboprophylaxis in this setting. Prolonged thromboprophylaxis after hospital discharge was seldom administered. 54% of surgeons used prolonged thromboprophylaxis after surgery for hip or femur fractures. During cast immobilisation of the upper leg, 79% of all surgeons prescribed thromboprophylaxis. CONCLUSION: Current practice regarding thromboprophylaxis during hospitalisation conformed consistently to the guidelines. The guidelines were followed moderately with regard to the use of prolonged thromboprophylaxis following hip fractures. In the absence of clear guidelines, there were striking differences among surgical practices regarding thromboprophylaxis during out-patient care and plaster cast immobilisation.

Effect of simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction.

This retrospective observational intravascular ultrasound study evaluated whether simvastatin therapy limits lumen area reduction 1-year after percutaneous transluminal angioplasty (PTA) by reducing reactive plaque growth, reducing reactive vasoconstriction, or both. This study showed that plaque growth is a general response 1 year after PTA regardless of the use of simvastatin; simvastatin has the potential to induce positive vascular remodeling, thereby reducing the occurrence of restenosis.

Progression of atherosclerosis at one-year follow-up seen with volumetric intravascular ultrasound in femoropopliteal arteries.

Volume measurements derived from intravascular ultrasound (IVUS) images assessed with an automated contour analysis system are accurate and reproducible. However, it is unknown to what extent plaque volume may change at follow-up. Therefore, the purpose of this longitudinal study is to examine whether IVUS is a sensitive means to identify progression of atherosclerosis and its derived primary end point plaque volume at 1-year follow-up. Patients (n = 11) undergoing percutaneous transluminal angioplasty (PTA) of the femoropopliteal artery were studied with IVUS immediately after PTA in the same session and at 1-year follow-up. Matched, well-identified vascular segments (3 to 4 cm in length), not subjected to PTA, imaged at baseline and after 1-year follow-up, were used for calculation of the longitudinal change in lumen, vessel and plaque volume, and mean plaque thickness. The median length of the selected vascular segments was 4 cm. At follow-up (12+/-2 months) a nonsignificant increase in lumen volume (2.3+/-11%), vessel volume (2.0+/-7.0%), and plaque volume (3.0+/-5.1%) was seen; the mean plaque thickness increase was 2.2+/-5.6%. In conclusion, progression of atherosclerosis implies changes in plaque and vessel volume, resulting in lumen volume change. This observation has important implications for future clinical trials aimed at monitoring the effect of pharmacologic agents on the progression and/or regression of atherosclerosis.

Early experience with intravascular ultrasound in evaluating the effect of statins on femoropopliteal arterial disease: hypothesis-generating observations in humans.

The purpose of this study was to compare the vascular response seen with intravascular ultrasound (IVUS) at 1-year follow-up between statin-treated and non-statin-treated patients. Patients (n = 10) undergoing percutaneous transluminal angioplasty (PTA) of the femoropopliteal artery were studied with IVUS immediately after PTA and at 1-year follow-up. In nondilated matched vascular segments, the change in lumen, vessel, and plaque volume was assessed. In balloon-dilated matched vascular segments, the change in lumen, vessel, and plaque area was assessed. A comparison was made between statintreated (n = 5) and non-statin-treated patients (n = 5) in lumen, vessel, and plaque changes. At follow-up, both statin-treated and non-statin-treated patients showed a similar increase in plaque volume at the nondilated segment (+4% and +2%, respectively). In statin-treated patients the plaque volume increase was compensated by an increase in vessel volume (+2%), resulting in an increase in lumen volume (+1%). In non-statin-treated patients, on the other hand, the increase in plaque volume was associated with a decrease in vessel volume (-2%), resulting in a decrease in lumen volume (-4%). At the balloon-dilated segment a similar trend in changes of lumen, vessel, and plaque was encountered. Differences between both groups of patients were not statistically significant. Despite the nonsignificant nature of the observation, this small retrospective IVUS study may generate the hypothesis that statin therapy may contribute to superior long-term lumen dimensions by inducing positive vascular remodeling both in nondilated and balloon-dilated vascular segments.

Plaque area increase and vascular remodeling contribute to lumen area change after percutaneous transluminal angioplasty of the femoropopliteal artery: an intravascular ultrasound study.

OBJECTIVE: The aim of the study was to assess the change in lumen area (LA), plaque area (PLA), and vessel area (VA) after percutaneous transluminal angioplasty (PTA) of the femoropopliteal artery. METHODS: This was a prospective study. Twenty patients were studied with intravascular ultrasound (IVUS) immediately after PTA and at follow-up examination. Multiple corresponding IVUS cross-sections were analyzed at the segments that were dilated by PTA (ie, treated sites; n = 168), including the most stenotic site (n = 20) and the nondilated segments (ie, reference sites; n = 77). RESULTS: At follow-up examination, both the PLA increase (13%) and the VA decrease (9%) resulted in a significant LA decrease (43%) at the most stenotic sites (P =.001). At the treated sites, the LA decrease (15%) was smaller and was caused by the PLA increase (15%). At the reference sites, the PLA increase (15%) and the VA increase (6%) resulted in a slight LA decrease (3%). An analysis of the IVUS cross-sections that were grouped according to LA change (difference >/=10%) revealed a similar PLA increase in all the groups: the type of vascular remodeling (VA decrease, no change, or increase) determined the LA change. At the treated sites, the LA change and the VA change correlated closely (r = 0.77, P <.001). At the treated sites, significantly more PLA increase was seen in the IVUS cross-sections that showed hard lesion or media rupture (P <.05). No relationship was found between the presence of dissection and the quantitative changes. CONCLUSION: At the most stenotic sites, lumen narrowing was caused by plaque increase and vessel shrinkage. Both the treated sites and the reference sites showed a significant PLA increase: the type of vascular remodeling determined the LA change at follow-up examination. The extent of the PLA increase was significantly larger in the IVUS cross-sections that showed hard lesion or media rupture.

Aortic graft infection by Lactobacillus casei: a case report.

A 65-year-old man with an abdominal aortic endoprosthesis presented with fever without other symptoms. Investigations revealed Lactobacillus casei bacteraemia. The Lactobacillus graft infection was at first successfully treated by antibiotic therapy. However, during follow-up a relapse occurred, and after surgical replacement of the graft the patient was cured. At surgery an aortoenteric fistula was found as source of the infection.

Partial unilateral phrenic nerve paralysis caused by a large intrathoracic goitre.

Intrathoracic goitres may cause a variety of symptoms caused by compression of the trachea, neural structures, blood vessels and the oesophagus. A case history is presented of a patient with a recurrent goitre after subtotal thyroidectomy who displayed partial unilateral phrenic paralysis, which subsided after a second subtotal thyroidectomy. Compression of the phrenic nerve appears to be a very rare manifestation of an intrathoracic goitre and thus far has never been reported.

[Screening for familial occurrence of abdominal aortic aneurysm]. / Screening op familiair voorkomen van aneurysma aortae abdominalis.

To detect familial occurrence of abdominal aortic aneurysms (AAA), the siblings of patients with an AAA were screened by ultrasonography. 128 siblings of 32 patients operated on for AAA were invited. 56 brothers and 52 sisters accepted the invitation. An AAA was diagnosed in 16 brothers (28.6%) and in 3 sisters (5.8%). Six of these siblings were operated on because of an aneurysmal diameter 20 mm in excess of that of the rest of the abdominal aorta, the others were included in a follow-up programme. We conclude that the prevalence of the AAA among brothers is higher in comparison with previously known risk groups and that the family of patients with an AAA are to be considered for screening first.

Mural collagen in experimental reflux esophagitis in rats.

Changes in the collagen content of the esophageal wall in reflux esophagitis were studied in rats subjected to surgically induced and biochemically monitored pancreaticobiliary reflux into the esophagus. Reflux periods of 7, 14, 28, and 42 days were followed by a reflux-abolishing operation, which resulted in healing of the esophagitis. The collagen content of the esophageal wall at the end of the reflux period was higher than control values obtained from normal nonoperated rats, with a significant difference after 42 days of reflux. Strictures were not observed. After abolition of the reflux the esophageal collagen content showed an initial drop, but then increased with the period of observation to give a significant rise (P less than 0.05) as compared with control rats which had been subjected to 7, 28, and 42 days of reflux. The meaning of the results for the understanding of the sequelae of reflux esophagitis is discussed.

Active trypsin and reflux oesophagitis: an experimental study in rats.

In order to clarify the role of active trypsin, bile acids and pepsin in reflux oesophagitis, a comparable series of experiments was performed in rats before and after reflux-inducing operations. Three control procedures were used--laparotomy (n = 10), oesophageal transection and reanastamosis (n = 7) and a Roux-en-Y reconstruction (n = 9)--and seven experimental procedures in order to produce gastric, bile and pancreatic reflux (G + B + P) (n = 9), gastric and pancreatic reflux (B + B) (n = 8), bile and pancreatic reflux (B + P) (n = 10), pancreatic reflux alone (P) (n = 9), gastric reflux alone (G) (n = 8), bile reflux alone (B) (n = 9) and gastric with bile reflux (G + B) (n = 9). Macroscopic and histologically confirmed oesophagitis was produced in groups G + B + P, G + P, B + P and P. The trypsin levels were significantly elevated in these groups, compared to both the control and other experimental groups (P less than 0.01). Bile acid levels were insignificantly different between the groups. Because these experiments involved vagal transection, no oesophagitis was found in the gastric juice reflux group. This study has shown for the first time a correlation between the presence of active trypsin in the oesophagus and the occurrence of oesophagitis. It is possible that active components of duodenal juice may contribute to the development of reflux oesophagitis in man.